Poly Medicure Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Monthly Indicators

Technical Momentum and Moving Averages Signal Strength

Poly Medicure’s current price stands at ₹1,731.75, up 1.16% from the previous close of ₹1,711.95, with intraday highs reaching ₹1,741.00 and lows at ₹1,683.50. The stock remains comfortably above its 52-week low of ₹1,184.00 but still below its 52-week high of ₹2,143.60, indicating room for upside potential. The daily moving averages have turned bullish, signalling positive short-term momentum and suggesting that buyers are gaining control.

The shift from a mildly bullish to a bullish technical trend on weekly charts reflects strengthening price momentum. This is corroborated by the Moving Average Convergence Divergence (MACD) indicator, which is bullish on a weekly basis, indicating that the stock’s short-term momentum is accelerating faster than its longer-term trend. However, the monthly MACD remains bearish, highlighting some caution for longer-term investors.

Mixed Monthly Indicators Temper Optimism

While weekly technicals show strength, monthly indicators present a more nuanced picture. The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This suggests that the stock is neither overbought nor oversold, providing a balanced outlook without extreme momentum pressures.

Bollinger Bands on the weekly chart are bullish, indicating price volatility is expanding upwards, which often precedes further gains. Conversely, the monthly Bollinger Bands are mildly bearish, signalling some resistance or consolidation at higher price levels over the longer term. Similarly, the Know Sure Thing (KST) indicator is bullish weekly but bearish monthly, reinforcing the mixed timeframe signals.

Volume and Dow Theory Confirm Positive Weekly Sentiment

On-Balance Volume (OBV) readings are bullish on both weekly and monthly charts, suggesting that volume trends support the price advances and that accumulation is occurring. This volume confirmation is critical as it validates the price moves and reduces the risk of false breakouts.

Dow Theory assessments also lean mildly bullish on both weekly and monthly timeframes, indicating that the broader market trend for Poly Medicure is positive but not yet strongly confirmed over the longer term. This mild bullishness aligns with the company’s recent upgrade in its Mojo Grade from Sell to Hold on 10 August 2026, reflecting improved technical and fundamental outlooks.

Comparative Returns Highlight Long-Term Outperformance

Poly Medicure’s stock returns have outpaced the Sensex over most time horizons, underscoring its relative strength within the healthcare services sector. Over the past week, the stock gained 0.82%, while the Sensex declined by 0.36%. The one-month return for Poly Medicure was a robust 5.04%, significantly higher than the Sensex’s 0.65% gain.

Year-to-date, the stock has declined by 2.48%, but this is notably better than the Sensex’s 9.34% fall, indicating relative resilience amid broader market weakness. Over the past year, the stock has underperformed with a 17.65% loss compared to the Sensex’s 3.52% decline, reflecting sector-specific or company-specific challenges during that period.

However, the medium to long-term picture is more favourable. Over three years, Poly Medicure has delivered a 20.29% return, slightly ahead of the Sensex’s 18.87%. The five-year return is particularly impressive at 86.30%, more than double the Sensex’s 37.67%. Over a decade, the stock has surged by 778.93%, vastly outperforming the Sensex’s 178.11% gain, highlighting its strong growth trajectory and compounding potential for long-term investors.

Technical Ratings and Mojo Grade Upgrade

The company’s Mojo Score currently stands at 57.0, with a Mojo Grade of Hold, upgraded from Sell on 10 August 2026. This upgrade reflects the improved technical parameters and a more constructive outlook on price momentum. The small-cap classification indicates that while the stock offers growth potential, it may carry higher volatility and risk compared to larger peers.

Investors should note the divergence between weekly and monthly technical indicators, which suggests that while short-term momentum is gaining strength, longer-term trends require further confirmation. The bullish daily moving averages and positive volume trends provide a solid foundation for near-term gains, but caution is warranted given the mildly bearish monthly MACD and Bollinger Bands.

Investor Takeaway: Balancing Momentum with Caution

Poly Medicure Ltd’s recent technical developments suggest a positive shift in price momentum, particularly on weekly and daily timeframes. The bullish MACD, moving averages, and OBV readings support a constructive near-term outlook, while the neutral RSI and mixed monthly indicators counsel prudence for longer-term investors.

Given the stock’s strong relative performance over the medium and long term, alongside its recent Mojo Grade upgrade, investors may consider adding or holding positions with appropriate risk management. However, the divergence in monthly technical signals and the stock’s small-cap status imply that volatility could persist, and monitoring key support and resistance levels remains essential.

Overall, Poly Medicure appears poised for further gains if weekly bullish momentum sustains, but investors should remain vigilant for any signs of monthly trend deterioration or broader market headwinds that could temper upside potential.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →